Reduced coenzyme Q10 derivative and method for production thereof

US9518004B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9518004-B2
Application numberUS-201314649369-A
CountryUS
Kind codeB2
Filing dateDec 2, 2013
Priority dateDec 3, 2012
Publication dateDec 13, 2016
Grant dateDec 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A reduced coenzyme Q 10 derivative represented by formula (1), wherein R 1 and R 2 are each independently H or an alkoxycarbonyl group represented by formula (2), and at least one of them is an alkoxycarbonyl group represented by the formula (2); in the formula (2), R 3 is an optionally substituted linear, branched, or cyclic alkyl group having 1 to 20 carbon atoms, an optionally substituted aryl group having 6 to 20 carbon atoms, or an optionally substituted heteroaryl group having 4 to 20 carbon atoms, and when R 3 is a group substituted with polyethylene glycol, the molecular weight of the polyethylene glycol is not more than 300.

First claim

Opening claim text (preview).

The invention claimed is: 1. A reduced coenzyme Q 10 derivative represented by formula (1), wherein R 1 and R 2 are each independently H or an alkoxycarbonyl group represented by formula (2), and at least one of R 1 and R 2 is an alkoxycarhonyl group represented by formula (2), and R 3 is a linear, branched, or cyclic alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms. 2. The reduced coenzyme Q 10 derivative according to claim 1 , wherein R 1 and R 2 are the same. 3. A crystal of a reduced coenzyme Q 10 derivative represented by formula (1), wherein R 1 and R 2 are each independently H or an alkoxycarbonyl group represented by formula (2), and at least one of R 1 and R 2 is an alkoxycarbonyl group represented by formula (2), and R 3 is a linear, branched, or cyclic alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms. 4. The crystal of the reduced coenzyme Q 10 derivative according to claim 3 , wherein R 3 is an ethyl group, an isopropyl group, an isobutyl group, a cyclopentyl group, or a phenyl group. 5. The crystal of the reduced coenzyme Q 10 derivative according to claim 3 , wherein R 1 and R 2 are the same. 6. A method for producing the reduced coenzyme Q 10 derivative according to claim 1 , comprising: reacting reduced coenzyme Q 10 represented by formula (3): with an alkoxycarbonylation agent in the presence of a base. 7. The method according to claim 6 , further comprising: forming crystals in an organic solvent. 8. The method according to claim 7 , wherein the organic solvent comprises one or more organic solvents selected from the group consisting of a nitrile, an alcohol, an aliphatic hydrocarbon, an aromatic hydrocarbon, a halogenated hydrocarbon, an ether, and an ester. 9. The method according to claim 7 , wherein the organic solvent is at least one of a nitrile and an alcohol. 10. The method according to claim 8 , wherein the organic solvent is a nitrile. 11. The method according to claim 10 , wherein the nitrile is acetonitrile. 12. The method according to claim 8 , wherein the organic solvent is an alcohol. 13. The method according to claim 12 , wherein the alcohol is ethanol. 14. The reduced coenzyme Q 10 derivative according to claim 1 , wherein R 1 and R 2 are each represented by the formula (2). 15. The crystal of the reduced coenzyme Q 10 derivative according to claim 3 , wherein R 1 and R 2 are each represented by the formula (2). 16. The crystal of the reduced coenzyme Q 10 derivative according to claim 4 , wherein R 1 and R 2 are the same. 17. The reduced coenzyme Q 10 derivative according to claim 1 , wherein R 3 is an ethyl group, an isopropyl group, a n-butyl group, an isobutyl group, a tert-butyl group, a cyclopentyl group, or a phenyl group. 18. The reduced coenzyme Q 10 derivative according to claim 1 , wherein R 3 is an isopropyl group, a cyclopentyl group, or a phenyl group. 19. The reduced coenzyme Q 10 derivative according to claim 18 , wherein R 1 and R 2 are the same. 20. The crystal of the reduced coenzyme Q 10 derivative according to claim 3 , wherein R 3 is a linear, branched, or cyclic alkyl group having 2 to 6 carbon atoms.

Assignees

Inventors

Classifications

  • Preparation of esters of carbonic or haloformic acids · CPC title

  • C07C69/96Primary

    Esters of carbonic or haloformic acids · CPC title

  • the ring being saturated · CPC title

  • Purification; Separation; Stabilisation · CPC title

  • Chemistry & Metallurgy · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9518004B2 cover?
A reduced coenzyme Q 10 derivative represented by formula (1), wherein R 1 and R 2 are each independently H or an alkoxycarbonyl group represented by formula (2), and at least one of them is an alkoxycarbonyl group represented by the formula (2); in the formula (2), R 3 is an optionally substituted linear, branched, or cyclic alkyl grou…
Who is the assignee on this patent?
Kaneka Corp
What technology area does this patent fall under?
Primary CPC classification C07C69/96. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).